文献速递腹部CT

基于CT的delta影像组学列线图评估局部进展期胃癌新辅助化疗后肿瘤退缩分级

CT-based delta-radiomics nomogram to assess tumor regression grade in locally advanced gastric cancer patients following neoadjuvant chemotherapy.
PubMed 文献 · Abdom Radiol (NY) · 2025-09-17

回顾性纳入147例局部进展期胃癌患者,比较勾画原发灶+最大淋巴结(P+L)与仅勾画原发灶(P)的delta CT影像组学模型,并构建联合临床因素的列线图。delta影像组学优于单期影像组学,P+L模型AUC训练集0.805、验证集0.795,列线图AUC训练集0.841、验证集0.817(P<0.05),可预测肿瘤退缩分级。

要点

  • 勾画原发灶+最大淋巴结的delta CT影像组学模型预测TRG优于仅勾画原发灶。
  • delta影像组学模型预测效能优于常规单期影像组学模型。
  • 联合delta影像组学与临床因素的列线图在全部模型中效能最佳。

核心结论

  • 同时勾画原发灶和最大淋巴结的delta CT影像组学列线图能准确预测局部进展期胃癌新辅助化疗后的肿瘤退缩分级。

研究设计与样本

  • 回顾性研究,纳入147例局部进展期胃癌患者,比较勾画原发灶+最大淋巴结(P+L)与仅勾画原发灶(P)两种ROI策略,提取影像组学特征构建模型,并将delta影像组学特征与临床变量联合构建列线图。

诊断标准与关键数值

  • delta CT影像组学P+L模型预测TRG的AUC:训练集0.805 vs 验证集0.727(原文此处写作delCT-RS P+L vs delCT-RS,按上下文应为P+L与P比较,训练集0.805 vs 0.727)。
  • delta CT影像组学P+L模型预测TRG的AUC:验证集0.795 vs 0.655(原文此处写作delCT-RS P+L vs delCT-RS,按上下文应为P+L与P比较,验证集0.795 vs 0.655)。
  • 联合delta CT影像组学P+L与临床因素的列线图预测TRG的AUC:训练集0.841,验证集0.817(P<0.05)。

临床应用与阅片要点

  • 作者认为该模型可准确预测TRG,有效识别可从新辅助化疗中获益的局部进展期胃癌患者,为个体化治疗提供科学支持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop and validate a delta computed tomography radiomics (delCT-RS) based nomogram for accurate preoperative prediction of tumor regression grade (TRG) in locally advanced gastric cancer (LAGC) patients following neoadjuvant chemotherapy (NAC).

METHODS: This retrospective study enrolled 147 LAGC patients. Two delineation strategies were compared: (1) contouring both the primary tumor and the largest lymph node (P + L) as regions of interest (ROIs), and (2) contouring only the primary tumor (P). Subsequently, radiomic features were extracted to construct corresponding radiomic models. This study compared the predictive accuracy of delCT-RS signatures to conventional single-phase radiomic signatures for TRG assessment. Then, delCT-RS signatures and clinical variables were combined into a nomogram. Finally, the prediction performance of nomogram was comprehensively evaluated.

RESULTS: In assessing tumor response, delCT-RS outperformed single-phase radiomic signatures. Notably, delta computed tomography delCT-RS P + L demonstrated superior accuracy to delCT-RS P (delCT-RS P + L vs. delCT-RS area under the curve (AUC): training cohort: 0.805 vs. 0.727; validation cohort: 0.795 vs. 0.655). The nomogram, combining delCT-RS P + L and clinical factors, achieved optimal performance among all models (training cohort AUC = 0.841; validation cohort AUC = 0.817). (p < 0.05) CONCLUSION: In this study, we innovatively employed a method that simultaneously delineated the primary tumor and the largest lymph node. This model can accurately predict TRG, effectively identify LAGC patients who can benefit from NAC, and provide scientific support for individualized treatment.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chen S, Xiao Z, Jin J, et al. CT-based delta-radiomics nomogram to assess tumor regression grade in locally advanced gastric cancer patients following neoadjuvant chemotherapy. Abdom Radiol (NY). 2025. PMID: 40960514. doi:10.1007/s00261-025-05171-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。